Style | Citing Format |
---|---|
MLA | Ghaznavi H, et al.. "Secondary Cancer Risk After Radiotherapy of Seminoma Stage One." Iranian Journal of Medical Physics, vol. 19, no. 3, 2022, pp. 175-180. |
APA | Ghaznavi H, Emami H, Allaveisi F, Shokrani P (2022). Secondary Cancer Risk After Radiotherapy of Seminoma Stage One. Iranian Journal of Medical Physics, 19(3), 175-180. |
Chicago | Ghaznavi H, Emami H, Allaveisi F, Shokrani P. "Secondary Cancer Risk After Radiotherapy of Seminoma Stage One." Iranian Journal of Medical Physics 19, no. 3 (2022): 175-180. |
Harvard | Ghaznavi H et al. (2022) 'Secondary Cancer Risk After Radiotherapy of Seminoma Stage One', Iranian Journal of Medical Physics, 19(3), pp. 175-180. |
Vancouver | Ghaznavi H, Emami H, Allaveisi F, Shokrani P. Secondary Cancer Risk After Radiotherapy of Seminoma Stage One. Iranian Journal of Medical Physics. 2022;19(3):175-180. |
BibTex | @article{ author = {Ghaznavi H and Emami H and Allaveisi F and Shokrani P}, title = {Secondary Cancer Risk After Radiotherapy of Seminoma Stage One}, journal = {Iranian Journal of Medical Physics}, volume = {19}, number = {3}, pages = {175-180}, year = {2022} } |
RIS | TY - JOUR AU - Ghaznavi H AU - Emami H AU - Allaveisi F AU - Shokrani P TI - Secondary Cancer Risk After Radiotherapy of Seminoma Stage One JO - Iranian Journal of Medical Physics VL - 19 IS - 3 SP - 175 EP - 180 PY - 2022 ER - |